Investing Profile

Stacie Weninger

InvestorVC

Executive Director at F-Prime

Your Intro Paths to Stacie Weninger

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Stacie is a member of

Harvard University Network

402 CONNECTIONS

Harvard University Network

52 CONNECTIONS

Fidelity Investments Network

21 CONNECTIONS

Find Stacie Weninger on

Current Investing Position

Investment Range

$100K - $10.0M

Sweet Spot

$5.0M

Investments On Record

Stacie Weninger is on these Sector & Stage Rankings

Stacie Weninger's Investments On Record (5)

Company	StageDateRound Size	Total Raised
Atalanta Therapeutics	Series BJan 2025$97M Series AJan 2021$110M	$210M
Co-investors: Jessica Alston (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Jason P. Hafler (Sanofi Ventures), Niall O’Donnell (RiverVest)
Tenvie Therapeutics	Series AJan 2025$200M	$200M
Co-investors: Paul Berns (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners), Alaa Halawa (Mubadala)
Engrail Therapeutics	Series BMar 2024$160M	$220M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Heath Lukatch (Red Tree Venture Capital), Jasper Bos (Forbion), Niall O’Donnell (RiverVest)
Neumora Therapeutics	Series AOct 2021$400M	$510M
Co-investors: Robert Nelsen (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners), Alaa Halawa (Mubadala)
Denali Therapeutics	Series BAug 2016$130M Series AMay 2015$220M	$350M
Co-investors: Doug Cole (Flagship Ventures), Robert Nelsen (ARCH Venture Partners)